LED Light Therapy for Psoriasis Australia: What Australians Should Know

• 14 min read
LED Light Therapy for Psoriasis Australia

LED light therapy for psoriasis Australia is a commonly researched topic — light-emitting diode (LED) technology uses specific visible wavelengths to interact with skin tissue through a mechanism called photobiomodulation, making it a different technology from the narrowband UVB phototherapy used clinically for psoriasis. Many Australians research LED devices alongside established psoriasis management, and this article explains what LED light therapy is, how it differs from UVB phototherapy and what the current research landscape looks like.

At a Glance

  • LED light therapy uses visible red (630-700nm) or near-infrared (700-1100nm) wavelengths — not ultraviolet light
  • The technology and mechanism of action differ fundamentally from narrowband UVB phototherapy used in dermatology clinics for psoriasis
  • Photobiomodulation — the proposed mechanism — involves light interaction with cellular components rather than UV radiation effects on skin cell turnover
  • Home LED devices for psoriasis are increasingly available in Australia; device specifications vary significantly across the market
  • Professional advice from a GP or dermatologist is appropriate before starting any light-based therapy for psoriasis

What Is LED Light Therapy?

LED light therapy uses arrays of light-emitting diodes to deliver specific wavelengths of visible or near-infrared light to the skin — a technology distinct from UVB phototherapy, laser devices and broadband light sources in its wavelength range, mechanism and evidence base.

Light-emitting diodes — LEDs are semiconductor devices that emit light at specific wavelengths when electrical current passes through them; they produce non-coherent, non-UV light at defined wavelengths; this contrasts with UV lamps (which emit ultraviolet radiation) and lasers (which produce coherent, highly concentrated light at specific wavelengths).

Visible red and near-infrared wavelengths — LED light therapy devices for skin applications typically use wavelengths in the visible red range (approximately 630-700nm) and/or near-infrared range (700-1100nm); these wavelengths are either visible as red light or just beyond visible range; they do not include UV wavelengths and do not produce UV-related effects on skin.

Photobiomodulation — the proposed biological mechanism through which LED therapy is studied; visible and near-infrared wavelengths are absorbed by chromophores in skin cells — particularly cytochrome c oxidase in mitochondria — potentially influencing cellular energy production (ATP synthesis) and downstream signalling including inflammatory pathways; researchers continue to investigate the specific mechanisms and their relevance to skin conditions.

Not equivalent to UVB lamps or lasers — LED devices differ from UVB phototherapy lamps in wavelength, mechanism and evidence base; they differ from medical lasers in the coherence and intensity of their light output; understanding these distinctions is important for accurate research into LED light therapy for psoriasis Australia.

Why Australians Research LED Light Therapy for Psoriasis

Home LED Devices

  • Commonly researched because: Home LED devices for skin applications are increasingly available in Australia across a wide price range; Australians with psoriasis commonly research whether home LED devices may complement their existing psoriasis management routine
  • Current understanding: Home LED devices vary substantially in wavelength accuracy, output intensity and build quality; published research on LED therapy for psoriasis has primarily used clinical-grade devices with defined specifications; the relationship between consumer-grade home device outcomes and clinical research findings is not straightforward
  • Things to compare: Whether the device publishes specific wavelength (nm) and output intensity (mW/cm²) information; whether the device specifications correspond to those used in research literature; device safety certifications and manufacturer transparency

Non-UV Technology

  • Commonly researched because: LED light therapy's use of visible rather than ultraviolet wavelengths is a commonly researched distinguishing feature for Australians comparing light-based options for psoriasis; some Australians research whether non-UV light-based options may be relevant alongside or as an alternative to UV-based approaches
  • Current understanding: LED light therapy's non-UV nature means it does not carry UV radiation exposure risks; however, the established clinical evidence base for psoriasis management is significantly more developed for narrowband UVB phototherapy; the two technologies are not interchangeable
  • Things to compare: The distinction between the well-established clinical evidence for UVB phototherapy in psoriasis and the still-developing research literature for LED therapy in psoriasis; professional assessment to determine which approach may be appropriate for a specific presentation

Skin Barrier Research

  • Commonly researched because: Psoriasis involves significant skin barrier dysfunction alongside the inflammatory and immune dysregulation driving plaque formation; some research has investigated whether photobiomodulation may influence barrier-relevant cellular processes
  • Current understanding: Research has examined red and near-infrared light's interaction with inflammatory signalling pathways relevant to psoriasis; laboratory studies have investigated effects on keratinocyte activity and cytokine production relevant to psoriatic inflammation; clinical evidence in psoriasis specifically is still developing and study results are mixed
  • Things to compare: The stage of evidence — laboratory findings (biological plausibility), small clinical studies (preliminary signals) vs larger controlled trials (clinical evidence); whether research used the same device specifications as the product being considered

Photobiomodulation

  • Commonly researched because: The term photobiomodulation appears in academic literature on LED therapy for skin conditions; Australians researching LED light therapy for psoriasis Australia commonly encounter this term and research its meaning and relevance
  • Current understanding: Photobiomodulation describes a field of research investigating how specific light wavelengths interact with biological tissue; the evidence base for photobiomodulation in psoriasis is at an earlier stage of development than for many established psoriasis management approaches; systematic reviews in this area note that studies have produced variable results and methodological inconsistency
  • Things to compare: Peer-reviewed literature vs manufacturer claims; in vitro and animal research vs human clinical trial evidence; study quality indicators including randomisation, control groups and sample size

Adjunct Skincare

  • Commonly researched because: Australians with psoriasis commonly research whether LED therapy may complement rather than replace their established psoriasis management including moisturisers, topical treatments and any prescribed management
  • Current understanding: If LED light therapy is considered, it would be an adjunct rather than a replacement for established psoriasis management; appropriate barrier-support moisturisers, prescribed topical management and regular dermatologist review remain the foundation of psoriasis care
  • Things to compare: Whether research studies used LED therapy alongside standard psoriasis management or as a standalone intervention; the importance of maintaining established management regardless of whether LED therapy is being explored

LED Light Therapy vs UVB Phototherapy

Understanding the technical differences helps Australians research each accurately and avoid confusing two fundamentally different technologies.

Type of light

  • LED light therapy: visible red light (630-700nm) or near-infrared (700-1100nm) — produced by light-emitting diodes
  • UVB phototherapy: ultraviolet B radiation (311-313nm narrowband UVB) — produced by specialised fluorescent or excimer lamps; invisible to the human eye

UV exposure

  • LED light therapy: no UV content — does not produce UV-related biological effects; no UV exposure risk
  • UVB phototherapy: UV radiation — the clinically active mechanism; requires dosing protocols, monitoring and appropriate safety measures

Typical device design

  • LED light therapy: LED panels, masks, handheld devices; available in consumer and clinical grades; wide range of specifications
  • UVB phototherapy: narrowband UVB lamps; used in dermatology clinic cabinets; home devices available for appropriate candidates under medical guidance

Current research focus

  • LED light therapy: photobiomodulation mechanisms; inflammatory pathway research; skin barrier cellular biology; still-developing clinical evidence base
  • UVB phototherapy: established clinical evidence base developed over decades; standard of care in clinical dermatology for moderate-to-severe psoriasis; established dosing protocols

Professional involvement

  • LED light therapy: typically self-purchased by consumers; professional guidance recommended before use for psoriasis management
  • UVB phototherapy: initiated and monitored by dermatologists in clinical settings; home-use UVB available for suitable candidates under professional guidance

For a detailed direct comparison, the guide to UVB vs LED light therapy and red light vs UVB cover the comparison in detail.

What Current Research Investigates

The research landscape for LED light therapy and psoriasis is active but the evidence base remains at an earlier stage of development than for UVB phototherapy.

Researchers have investigated photobiomodulation's potential effects on inflammatory processes relevant to psoriasis; psoriatic inflammation involves dysregulated keratinocyte proliferation and a specific cytokine environment (including IL-17, IL-23 and TNF-α pathways); laboratory studies have examined whether red and near-infrared wavelengths may influence these pathways.

Clinical studies of LED therapy in psoriasis have produced mixed results — some small studies have reported reductions in psoriasis severity scores, while others have shown minimal effect; methodological differences between studies (wavelength, intensity, treatment protocol, control conditions) make direct comparison difficult and meta-analyses challenging.

Evidence is still evolving — systematic reviews of low-level light therapy for psoriasis have generally noted that while preliminary findings are of research interest, the evidence base is insufficient for firm clinical recommendations; larger, better-controlled trials with consistent device specifications and outcome measures are needed.

Areas currently being investigated include: optimal wavelength parameters for psoriasis applications (whether red 660nm, near-infrared 830nm or combined protocols produce different effects), appropriate treatment frequency and duration, comparison with established topical management, and whether certain psoriasis presentations may be more responsive than others.

Australians researching LED light therapy for psoriasis Australia benefit from understanding the distinction between research interest (which is genuine and ongoing) and established clinical evidence (which for LED therapy in psoriasis is less developed than for UVB phototherapy or established systemic and topical treatments).

What Australians Compare Before Buying an LED Device

The LED light therapy device market in Australia includes products from clinical-grade to consumer-grade at very different price and specification levels — these are the most commonly researched comparison points.

Published wavelength specifications — the most critical technical comparison point; a device should publish specific wavelength outputs (e.g., 660nm red, 830nm near-infrared) rather than generic terms; specific wavelengths can be compared with those used in published research.

Output intensity and energy delivery — power density (mW/cm²) and energy fluence (J/cm²) determine the light dose delivered to skin; clinical research studies specify these parameters; consumer devices may not publish this information, making comparison with research protocols difficult.

Intended device purpose — LED devices marketed for facial skin applications differ from those intended for body use; psoriasis commonly affects the elbows, knees, scalp and body — matching device coverage to the affected area matters for practical use.

Manufacturer information — Australian consumers benefit from devices with clear manufacturer details, TGA regulatory information where applicable, warranty terms and accessible customer support; these indicate a more transparently operated product.

Safety instructions — LED light therapy devices should provide clear safety guidelines; while red and near-infrared light does not produce UV effects, appropriate use instructions including eye safety and use around specific conditions should be clearly stated.

Cost in context — home LED devices range from modest to premium price points in Australia; price does not reliably indicate device quality or clinical relevance; researching specifications rather than cost is more informative for psoriasis-focused research.

Buying Checklist

Before purchasing an LED light therapy device for psoriasis:

☐ Specific wavelengths published? — exact nm values rather than "red light" or "near-infrared"
☐ Output intensity disclosed? — mW/cm² and/or J/cm² if available
☐ Device coverage suits affected areas? — facial vs body vs targeted coverage
☐ Manufacturer details available? — warranty, TGA information, support contact
☐ Safety instructions clear? — eye safety, contraindications, usage protocols
☐ Professional advice obtained? — GP or dermatologist discussion before starting

Common Buying Mistakes

Assuming LED and UVB are the same technology — LED light therapy uses visible wavelengths through photobiomodulation; UVB phototherapy uses ultraviolet radiation with a different mechanism and established clinical evidence base for psoriasis; treating them as equivalent misrepresents both technologies.

Buying devices without wavelength information — devices that do not specify exact output wavelengths cannot be meaningfully compared with research literature; wavelength specificity is the minimum technical information needed for informed LED device selection.

Comparing products solely by price — price does not reliably indicate wavelength accuracy, output consistency or clinical relevance; a device that publishes transparent specifications at a modest price may be more appropriate than an expensive device with vague marketing claims.

Ignoring manufacturer support — LED devices require ongoing use over weeks to months; warranty terms, device durability and accessible customer support are practical considerations that affect the long-term usefulness of a device.

Expecting identical outcomes from all devices — LED devices vary substantially in their technical specifications; the same outcome cannot be expected from devices with different wavelengths, intensities and protocols even if marketed for the same purpose.

Products Commonly Researched at Australian Psoriasis and Eczema Supplies

The LED Mask Facial Red Light Therapy is commonly researched by Australians investigating LED light therapy for facial psoriasis presentations — LED mask format providing facial coverage for research into visible-wavelength light therapy.

The Red Light Therapy Face Mask is commonly researched alongside other LED facial devices for Australians comparing home LED options for facial skin conditions including psoriasis.

For UVB phototherapy — a different technology with a significantly more established clinical evidence base for psoriasis — the light therapy collection covers UVB devices commonly researched by Australians with psoriasis under GP or dermatologist guidance.

The full red light therapy collection covers LED and red light therapy device options commonly researched by Australians investigating visible-wavelength light therapy for psoriasis and other skin conditions.

Related Guides

Learn More

Compare

Shop

Frequently Asked Questions

What is LED light therapy?
LED light therapy uses arrays of light-emitting diodes to deliver specific wavelengths of visible red (630-700nm) or near-infrared (700-1100nm) light to the skin through a proposed mechanism called photobiomodulation. It is distinct from UVB phototherapy (which uses ultraviolet wavelengths and has a different mechanism and established clinical evidence base for psoriasis), from lasers (which produce coherent high-intensity light) and from broadband light sources. Home and clinic LED devices are available in Australia across a wide range of specifications and price points.

Is LED light therapy the same as UVB therapy?
No — LED light therapy and UVB phototherapy are fundamentally different technologies. LED light therapy uses visible red or near-infrared wavelengths (630-1100nm) with no UV content; UVB phototherapy uses ultraviolet B wavelengths (311-313nm narrowband UVB) that are invisible to the human eye. Their mechanisms of action differ entirely — photobiomodulation for LED therapy vs UV radiation effects on skin cell turnover and immune function for UVB phototherapy. The clinical evidence base for UVB phototherapy in psoriasis is significantly more developed than for LED light therapy.

Why do Australians research LED light therapy for psoriasis?
Several factors drive Australian interest in LED light therapy for psoriasis: the increasing availability of home LED devices, the technology's use of visible rather than ultraviolet wavelengths, ongoing research into photobiomodulation's effects on inflammatory pathways relevant to psoriasis, and the desire to complement standard psoriasis management. Australians researching this area benefit from understanding that the evidence base for LED light therapy in psoriasis is still developing, and that established psoriasis management — appropriate skincare, topical treatments and dermatologist guidance — remains the foundation of care.

What should I compare before buying an LED light therapy device for psoriasis?
Published wavelength specifications (specific nm values rather than "red light") are the most important technical comparison point for matching a device to research literature. Output intensity (mW/cm²) if disclosed, device coverage relative to psoriasis-affected areas, manufacturer transparency (warranty, TGA information, support), clear safety instructions and appropriate price-to-specification assessment are all commonly researched before purchase. Professional advice from a GP or dermatologist before starting is consistently the most important pre-purchase step.

When should I seek professional advice about LED light therapy for psoriasis?
Professional advice from a GP or dermatologist is appropriate before starting LED light therapy for psoriasis — particularly if psoriasis is moderate to severe, if current management is not achieving satisfactory results, or if UVB phototherapy (which has a significantly more established clinical evidence base for psoriasis) has not been discussed. A dermatologist can assess whether UVB phototherapy may be more appropriate, advise on the role of any adjunct approaches including LED therapy, and ensure light-based therapy is considered alongside optimised psoriasis management rather than as a replacement.

Key Takeaways

  • LED light therapy uses visible wavelengths — not UV — photobiomodulation through visible red and near-infrared wavelengths is a different mechanism from UV radiation effects in UVB phototherapy; the two are not interchangeable
  • The evidence base is developing — research into LED therapy for psoriasis is ongoing; preliminary laboratory and small clinical findings are of research interest but the evidence base is less established than for UVB phototherapy or approved systemic psoriasis treatments
  • Device specifications matter — published wavelength (specific nm values), output intensity and manufacturer transparency are more informative than price or marketing claims for informed LED device comparison
  • Adjunct not replacement — LED light therapy, if explored, would be an adjunct to rather than a replacement for established psoriasis management including appropriate skincare, topical treatments and dermatologist review
  • Professional advice before starting — a GP or dermatologist can assess whether psoriasis management is optimised, discuss appropriate light-based options and guide informed device selection if relevant

When to Seek Medical Advice

Anyone considering LED light therapy for psoriasis Australia should discuss this with a GP or dermatologist before starting — particularly if psoriasis is persistent, moderate to severe, or if current management is insufficient. A dermatologist can assess whether UVB phototherapy (which has a substantially more established clinical evidence base for psoriasis) may be more appropriate for your presentation, advise on the role of adjunct approaches including LED therapy, and ensure that light-based therapy is being considered alongside optimised established management rather than in place of it.

According to Healthdirect Australia, persistent psoriasis should be managed with professional guidance. DermNet NZ on phototherapy provides comprehensive clinical detail on light-based therapies for psoriasis including the distinction between established and investigational approaches.

This is an educational resource — not medical advice. Consult a GP or dermatologist for personalised advice on psoriasis management and light-based therapy options.

Australia LED Light Therapy Psoriasis Psoriasis Flare Ups psoriasis light therapy Red light therapy